Research is being conducted on the safety and efficacy of various therapies, including B-cell therapy, in older individuals with multiple sclerosis and other conditions. Some studies suggest that certain treatments, such as chimeric antigen receptor T-cell therapy, may be equally effective and safe in older and younger patients. The outcomes of these therapies in older populations are being explored in various studies and presented at medical conferences.